Minimally invasive surgery for the treatment of hyperacusis: New technique and long term results.


Journal

American journal of otolaryngology
ISSN: 1532-818X
Titre abrégé: Am J Otolaryngol
Pays: United States
ID NLM: 8000029

Informations de publication

Date de publication:
Historique:
received: 11 10 2019
accepted: 15 10 2019
pubmed: 16 11 2019
medline: 14 4 2020
entrez: 16 11 2019
Statut: ppublish

Résumé

A minimally invasive surgery developed by the senior author has previously been reported to significantly improve sound tolerance after surgery. This report compares the new versus original surgical technique used and long-term results of all patients who have undergone minimally invasive surgery for hyperacusis. A prospective, IRB approved clinical research trial at a single institution with surgery performed by the author (HS). All patients were evaluated and treated at a tertiary level otologic referral center. 47 subjects were enrolled from 2014 through 2019, 40 met inclusion criteria including adequate follow-up in the analysis. All subjects underwent oval and round window reinforcement. 20 subjects underwent surgery before 2017 with the original technique of round window reinforcement. 20 subjects underwent new technique with additional oval window and stapes reinforcement. 80% of subjects who underwent the new surgical technique had improvement in hyperacusis symptoms after surgery compared to 60% of subjects who underwent the original technique. Long term follow-up showed sustained results with both techniques with a mean follow-up of 2 years after surgery. The most recent, newer technique employed appears to have an 80% success rate in improving sound tolerance with small changes to hearing. The improvement in hyperacusis symptoms after surgery is significant and now found to be sustainable with a mean follow-up of 2 years after initial surgery. Psychological measures of anxiety and depression also were found to be significantly improved after surgery in the newer technique group.

Identifiants

pubmed: 31727335
pii: S0196-0709(19)30940-8
doi: 10.1016/j.amjoto.2019.102319
pii:
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102319

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Herbert Silverstein (H)

Ear Research Foundation, 1901 Floyd Street, Sarasota, FL 34239, United States. Electronic address: Hsilverstein@earsinus.com.

Brian Kellermeyer (B)

Ear Research Foundation, 1901 Floyd Street, Sarasota, FL 34239, United States.

Ulyseius Martinez (U)

Ear Research Foundation, 1901 Floyd Street, Sarasota, FL 34239, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH